Mangold C, Ksiazek I, Yun S-W, Berger E, Binkert C
Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland.
Neuropeptides. 2008 Aug;42(4):377-86. doi: 10.1016/j.npep.2008.04.008. Epub 2008 Jun 10.
Neuromedin U (NMU), a neuropeptide implicated in feeding, inflammation, pain control and anxiety-related behaviours, is widely distributed in peripheral organs and the CNS. These effects are thought to be mediated by its receptors NMU(1) and NMU(2). Since its precise sites of interaction in the CNS were to date unknown, we studied the distribution of in vitro binding sites for (125)I-NMU-23 in the rat CNS by receptor autoradiography. High-density specific binding was found in discrete areas of the brain and spinal cord, namely in the limbic system (hippocampal formation, septohippocampal nucleus, indusium griseum, hypothalamus, amygdaloid nuclei), superior colliculus, dorsal raphé, and substantia gelatinosa of the spinal cord. Our findings provide further supportive evidence for a multifunctional role for the peptide in the brain and spinal cord.
神经介素U(NMU)是一种与进食、炎症、疼痛控制及焦虑相关行为有关的神经肽,广泛分布于外周器官和中枢神经系统(CNS)。这些作用被认为是由其受体NMU(1)和NMU(2)介导的。由于其在中枢神经系统中精确的相互作用位点迄今尚不清楚,我们通过受体放射自显影术研究了大鼠中枢神经系统中(125)I-NMU-23体外结合位点的分布。在脑和脊髓的离散区域发现了高密度的特异性结合,即在边缘系统(海马结构、隔海马核、灰被、下丘脑、杏仁核)、上丘、中缝背核和脊髓胶状质。我们的研究结果为该肽在脑和脊髓中的多功能作用提供了进一步的支持证据。